Sorry for posting my new study in a weekday, but I won't be available on this weekend for a complete write up of this post. Hence decided to go ahead today. However, I will be replying to the queries if any.
Swiss Glascoat Equipments Ltd. (SGEL) is based in western part of India, specializes in design and manufacturing of Carbon Steel Glass Lined Equipment viz. Reactors, Receivers / Storage Tanks, Driers, Filters, Columns, Agitators, Valves, Pipes & Fittings.
Swiss Glascoat Equipments caters to requirement of leading Pharmaceutical / API, Specialty Chemicals, Dies / Colors, Agro Chemicals, Food Processing and allied Industries.
Experience spanning two decades, a portfolio comprising over 8,000 glass-lined equipment and as pioneers of many customised processes, Glascoat is well-recognised for excellence in glass-lining industry.
The Company's glasscoat product range consists of both ready-made and custom-built equipment. Apart from names mentioned above, the company's other products include Glass Lined Flush Bottom Outlet Valve, Bellows-Sealed Valve, Glass Lined Diaphragm Valve, Flanged Pipe, Flanged Elbows 90, Flanged Crosses, Reducing Flanges and Flanged T- Pieces with reduced connection.
The core element of the Glass line industry lies in the technology for manufacturing of glass frit and its applications.
Swiss Glascoat Equipments has established itself as an One-Point-Solution-Provider for glass-line products of any type, size, output plus a complete range of accessories.
More details related to products of the company is shared in the video below.
This has led to company attracting plenty of big companies in pharma, speciality chemical and agro sector.
Some of the major clients of the company are:
1) Aurobindo Pharma
2) Divis Lab
3) Glenmark Pharma
4) Themis Medicare
5) Shasun Pharma
6) Sanofi
7) Atul
8) BASF
9) SRF
10) Bayer CropScience
and many more.......................
In a way, we can conclude that success of these companies will indirectly lead to success of Swiss Glascoat Equipments. Most of the names mentioned here, are already big players and are likely to continue posting good growth going ahead, which enhances my confidence in this company and its growth.
A Virtual Tour Video Of The Company:
Talking about risk and other details, according to my study, there are 3 main players in this industry, with GMM Pfaudler, being the only listed company other than Swiss Glascoat Equipments. However, as per annual reports, it is seen that 2 more companies have entered this business, which is likely to challenge the company and might affect their profitability. Lack of expertise in manpower is also one of the negatives. Apart from that, rising inflation over last few years, was also a worry, along with rising fuel and electricity charges.
This is one part of challenge which seems to be neutralizing as this year, we have seen a good dip in inflation as well as fuel cost.
Talking about the numbers, it has remained flat over past few years, but things are expected to change now, as the company is gaining popularity among the big names in pharma, chemicals and agro space. The compounded sales growth and compounded profit growth i.e. CAGR for past 5 years has been 12% and 15% respectively, which is moderate.
Results in FY'14 were not that attractive when compared with FY'13, as sales and profit remained flat for the entire year, but there are some positives this year.
So far, for the first six months ended Sept 14, the company has reported 39% growth in sales and 33% growth in net profit. The debt levels reduced to half in FY'14 when compared with FY'13, though it has increased slightly in first six months of this year. The debt to equity ratio is below 1, which is also good. The cash flow of the company at operating level has always remained positive in last 10 years, which signifies the excellent operational efficiency of the company. The dividend payout so far has been excellent and the average payout ratio has remained around 28% which is very good for such a small company.
Speaking about its comparison with GMM Pfaudler, the largest listed player, in terms of market cap, GMM Pfaudler is trading at 7 times the value of Swiss Glascoat. Swiss Glascoat is trading at market cap of close to 50 Cr, where as GMM Pfaudler is trading at around 350 Cr, though one has to also consider the fact that GMM Pfaudler has a more stable fundamentals than Swiss Glascoat at present.
The challenge for the company now is to fight this battle and keep growing bigger, and probably challenge GMM Pfaudler one day.
On the basis of FY'14 earning, where company reported 7.61 EPS for the full year, it is currently trading at a P/E ratio of 13. However, for the first six months this year, the EPS stands at 4.26, and the company looks promising to kiss levels around 9 for the full year this time, which will make the P/E come down to 11 at current market price.
Note:
Looking at overall data, I like the company, their prospectus, and their numerical data so far in terms of quarterly results and balance sheet. However as always, the decision to invest in company or not, is up to the reader to decide, and the author doesn't take any liability for the same.
Off-late, we have seen plenty of volatility in markets, which has scared many small investors. For them, I will reply once again, that it is very difficult for me to comment on short term movements of specific stocks, as I believe in long term investments for good returns.
If there is any negative news flow related to any company discussed over here, even that will be shared with all readers. So, all the updates will be given, but that just has to be used as reference by all readers, and make their own decision based on their belief.
Happy Investing!!!!!
Swiss Glascoat Equipments Ltd. (SGEL) is based in western part of India, specializes in design and manufacturing of Carbon Steel Glass Lined Equipment viz. Reactors, Receivers / Storage Tanks, Driers, Filters, Columns, Agitators, Valves, Pipes & Fittings.
Swiss Glascoat Equipments caters to requirement of leading Pharmaceutical / API, Specialty Chemicals, Dies / Colors, Agro Chemicals, Food Processing and allied Industries.
Experience spanning two decades, a portfolio comprising over 8,000 glass-lined equipment and as pioneers of many customised processes, Glascoat is well-recognised for excellence in glass-lining industry.
The Company's glasscoat product range consists of both ready-made and custom-built equipment. Apart from names mentioned above, the company's other products include Glass Lined Flush Bottom Outlet Valve, Bellows-Sealed Valve, Glass Lined Diaphragm Valve, Flanged Pipe, Flanged Elbows 90, Flanged Crosses, Reducing Flanges and Flanged T- Pieces with reduced connection.
The core element of the Glass line industry lies in the technology for manufacturing of glass frit and its applications.
Swiss Glascoat Equipments has established itself as an One-Point-Solution-Provider for glass-line products of any type, size, output plus a complete range of accessories.
More details related to products of the company is shared in the video below.
This has led to company attracting plenty of big companies in pharma, speciality chemical and agro sector.
Some of the major clients of the company are:
1) Aurobindo Pharma
2) Divis Lab
3) Glenmark Pharma
4) Themis Medicare
5) Shasun Pharma
6) Sanofi
7) Atul
8) BASF
9) SRF
10) Bayer CropScience
and many more.......................
In a way, we can conclude that success of these companies will indirectly lead to success of Swiss Glascoat Equipments. Most of the names mentioned here, are already big players and are likely to continue posting good growth going ahead, which enhances my confidence in this company and its growth.
A Virtual Tour Video Of The Company:
Talking about risk and other details, according to my study, there are 3 main players in this industry, with GMM Pfaudler, being the only listed company other than Swiss Glascoat Equipments. However, as per annual reports, it is seen that 2 more companies have entered this business, which is likely to challenge the company and might affect their profitability. Lack of expertise in manpower is also one of the negatives. Apart from that, rising inflation over last few years, was also a worry, along with rising fuel and electricity charges.
This is one part of challenge which seems to be neutralizing as this year, we have seen a good dip in inflation as well as fuel cost.
Talking about the numbers, it has remained flat over past few years, but things are expected to change now, as the company is gaining popularity among the big names in pharma, chemicals and agro space. The compounded sales growth and compounded profit growth i.e. CAGR for past 5 years has been 12% and 15% respectively, which is moderate.
Results in FY'14 were not that attractive when compared with FY'13, as sales and profit remained flat for the entire year, but there are some positives this year.
So far, for the first six months ended Sept 14, the company has reported 39% growth in sales and 33% growth in net profit. The debt levels reduced to half in FY'14 when compared with FY'13, though it has increased slightly in first six months of this year. The debt to equity ratio is below 1, which is also good. The cash flow of the company at operating level has always remained positive in last 10 years, which signifies the excellent operational efficiency of the company. The dividend payout so far has been excellent and the average payout ratio has remained around 28% which is very good for such a small company.
Speaking about its comparison with GMM Pfaudler, the largest listed player, in terms of market cap, GMM Pfaudler is trading at 7 times the value of Swiss Glascoat. Swiss Glascoat is trading at market cap of close to 50 Cr, where as GMM Pfaudler is trading at around 350 Cr, though one has to also consider the fact that GMM Pfaudler has a more stable fundamentals than Swiss Glascoat at present.
The challenge for the company now is to fight this battle and keep growing bigger, and probably challenge GMM Pfaudler one day.
On the basis of FY'14 earning, where company reported 7.61 EPS for the full year, it is currently trading at a P/E ratio of 13. However, for the first six months this year, the EPS stands at 4.26, and the company looks promising to kiss levels around 9 for the full year this time, which will make the P/E come down to 11 at current market price.
Note:
Looking at overall data, I like the company, their prospectus, and their numerical data so far in terms of quarterly results and balance sheet. However as always, the decision to invest in company or not, is up to the reader to decide, and the author doesn't take any liability for the same.
Off-late, we have seen plenty of volatility in markets, which has scared many small investors. For them, I will reply once again, that it is very difficult for me to comment on short term movements of specific stocks, as I believe in long term investments for good returns.
If there is any negative news flow related to any company discussed over here, even that will be shared with all readers. So, all the updates will be given, but that just has to be used as reference by all readers, and make their own decision based on their belief.
Happy Investing!!!!!
Excellent post. thanks.
ReplyDeleteHello Kunal, can we buy it now?
ReplyDeleteAnswer is already given in the last para of the post... :)
DeleteSo finally, we have the first 10 bagger stock of this blog...
ReplyDeleteAjanta Pharma hit new high of 2720 Rs today, where as it suggested, when it was trading at 272 Rs adjusted to bonus shares given by the company last year...
congrats dear Kunal!!!!
DeleteThank you..:)
DeleteHello Kunal, Thanks for the post. Can I ask in different ways, do you have it in your portfolio recently. :-) Thanks.
ReplyDeleteYes, and I am holding almost all the stocks discussed here...
DeletePlease let me know ur views on control print?
ReplyDeleteControl Print is already discussed stock on this blog..
Deleteplease check left hand side widget to find all the stocks followed...
If I have to choose between Garware n Swiss Glasscoat, which one would you prefer most?
ReplyDeleteI understand both are in different sector n don't wanna do any comparison but cannot invest in both due to capital crunch. So which one is more rewarding bet according to you. Pls don't be deplomatic again while answering 😉
-Mayur
I look diplomatic in my answers because even I don't know which one is going to appreciate at what pace..
DeleteWhen I started this blog, I had a same feeling for Photoquip and Ajanta Pharma, but you can see the difference today, one has given mild de-growth in 2.5 years, while the other has become 10 bagger. So really its not up to me to tell you which one is going to appreciate more....
And whenever you are in capital crunch, there is always an option of dividing the allocation between 2 or 3.. However, that's personal wish..
Garware is placed in bad sector, which could restrict the jump up, while Swiss is better placed in that matter, though its a new sector for me too...
Hi Kunal, Please let us know your take on SBI and ICICI Bank?
ReplyDeleteSorry but not tracking any large caps stocks at present...
DeleteHi kunal have u checked the announcement of Capri Global? Their board meeting is scheduled on 19 december to decide for merger of 4 wholly owned subsidies with themselves and also for investment in a joint venture abroad. How much it will be beneficial for the company? Can u throw some limelight regarding it... Thanks..
ReplyDeleteHaven't checked it... not at my home this weekend as mentioned in this post...
DeleteWill check the details and let you know..
Regarding the KOPRAN LTD , I have bought 500 @ 60 now @53.90 can i hold or another buy this current level.
ReplyDeleteHad it in my watchlist earlier, but left it after 2-3 poor quarterly numbers...
DeleteHave stopped tracking after that, as many better pharma bets are available at cheaper price in my opinion...
Dear Kunal
ReplyDeleteCould you share your view on the following news
Capri global -Merger of four wholly owned subsidiary companies with the Company;
Do you think its really positive?
CTS
Positive, if you are ready to wait for long term...
DeleteDon't see any immediate impact...
Hi Kunal holding SKM Eggs for long term.kindly share your views.
ReplyDeleteAs of now not tracking the stock, but I can see lot of discussion happening related to this company..
DeleteWill try studying it and then give you some conclusion..
Thx will wait for your study.
ReplyDeleteSir, waiting for your update. Have you studied SKM Eggs?
DeleteIt is not possible to do it in a week day, as I am busy with my work...
DeleteNeed some time...
Will try to do it soon..
Hi Kunal, congrats for ajanta pharma,
ReplyDeleteplease share your views on wa tech wabag and vst tillers?
Had both in my radar, but stopped tracking after both had a tremendous run up.. VST from 600 to 1900 and Wa Tech from 500 to 1700..
DeleteSuddenly I felt both became expensive and hence stopped tracking..
No idea about their recent updates..
Will have a look sometimes later and figure out if they are strong enough once again..
Kunal, Gulshan Polyols gave very dissapointing results on the margin side, though admittedly the revenues were great. The fear is it goes back to its mediocre performance of 2- 3 years ago. Is that a concern for you?
ReplyDeleteNot much, especially after looking at severe decline in crude prices, as high crude prices was one of the big reason to keep margins in check earlier...
DeleteExpecting very good Q3 and excellent Q4, with commercialization of new operations...
Because of such new operations, I won't mind, even if margins are under check for a year or so, as I am sure, it will start delivering once new operations stabilizes..
And in case, if it is just about profits, one has also understand the fact that it is still trading at a P/E ratio below 10.. :)
Hi Kunal,
DeleteCould you please explain as to how Gulshan Polyols will be a direct beneficiary arising out of crude prices getting halved ?
totalview
It is not direct beneficiary, but it will benefit to an extent, as mentioned in the comment made yesterday, towards the end of this page...
DeleteIf it seems like direct beneficiary from this comments, then apologies for that, as I didn't mean that..
If you see the expenses of last year, when they made a total revenue of 327 Cr, the power and fuel consumption accounted for 93 Cr out of the total expense of 278 Cr, which is a significant amount.
By that, I feel they should be benefited this year, with prices of crude and crude derivatives coming down...
Let me add that Gulshan Polyols has started work on it's grain based distillery project at Chhindwara, MP !!! ENA project is slated to be completed within 12 to 15 months and cost of project is Rs.50 crores. Meanwhile, bottling project has started production and it is being branded as "Tiger Gold" They have plans to introduce many more brands in the market.
Deletetotalview
Are you tracking Polyplex Corp?
ReplyDeleteSorry, not tracking Polyplex...
Deletehi,
ReplyDeletehad you gone through capri global merger and JV with noor capital (uae)..is it good or bad
Yes, I have gone through it..
DeleteFirstly the 4 companies mentioned that will be merged, are operating at a very small level currently, so don't think, that merger is going to make any changes to the fundamentals of the company..
Secondly, the investment in joint venture, looks interesting. It could benefit the company in long run, as Noor Capital seems to be very well established investment house in UAE...
Hey kunal, do you any idea about Aarti Drugs?
ReplyDeletePositive on Aarti Drugs..
DeleteAt current market price, I think, Aarti Drugs and Granules India, are equally placed, though Granules India has better future prospectus, in my opinion...
Aarti Drugs itself is not a bad option though...
Hi Kunal,
ReplyDeleteCould you please suggest a couple of companies which would get benefitted from lower crude prices. Looks like even if there is a bounce back in crude, it will not cross 70-75 any time soon.
Please suggest a couple of good companies which would be benefitted because of this. Thanks for all your help.
Regards,
Jay
Hi Jay,
DeleteOverall if you see, the biggest beneficiaries would be the Auto stocks, where the cost of owing a vehicle is coming down, which eventually will lead to more buyers.
Apart from that, Paint companies, and FMCG will benefit more, as their raw material cost is almost directly linked to crude price...
I can't give you specific names, but likes of company in plastic, and specialty chemicals will also get benefited to an extent...
Hope that helps..
Regards.
Thanks Kunal, appreciate your quick reply.
ReplyDeleteRegards,
Jay
Can Gulshan Polyols bought at current price?
ReplyDeleteThat you yourself has to decide..
DeleteI am positive on it, with reasons given above..
Hi kunal, are you tracking motherson sumi? if yes, please share your views on it.
ReplyDeleteNot strictly tracking, but its a large company, with pretty decent management and fundamentals..
DeleteGood stock for core portfolio, for steady returns. Doubt its multibagger potential, from current valuations...
How is Prima Plastics placed at cmp 58 as crude oil is on downfall consistently? is it worth to take some action on it?
ReplyDelete-mayur
Crude will benefit, but not sure about the company's potential, don't find it so attractive... will have to study more...
DeleteCould you share your view on Trident? Thanks Kabi
ReplyDeleteHi Kabi,
DeleteWe had a very detailed discussion related to Trident some 6 months ago on:
http://fundamentalstockideas.blogspot.in/2014/06/tcpl-packaging-probable-candidate-to.html
Please use search functionality to find related comments...
No change in views since then..
Company might be good, but I am not convinced based on my personal belief...
Regards.
Thanks Kunal, got it. Do you think that the equity dilution will affect the stock price (any scrip) over the long run/short run?
DeleteI am never in favour of equity dilution, as I feel high liquidity reduces the possibility of strong re-rating...
DeleteThats just my personal opinion though.. :)
Hi Kunal Vidhi dyestuffs is in same business of DP but a larger co....what's your view.
ReplyDeleteHi Salim,
DeleteMy observations says that Dynemic has much better margins as well as good consistency in terms of quarterly results than Vidhi..
Plus, the debt:equity ratio is much stable for Dynemic than Vidhi..
Kindly let me know if you have some positives on Vidhi over Dynemic...
Thanks kunal kindly let me have you email id to share info on vid hi.
ReplyDeletekunal25184@gmail.com
DeleteThere is nothing wrong in posting the details here itself... :-)
Deleteany updates on Ganesh Ecosphere?
ReplyDeleteNo change in fundamentals since recommendation... hence no change in views..
DeleteKunal email sent through khansalimx@gmail.com
ReplyDeletewill try to check soon, thanks...
Deletepls share your views on Granules India at current price?
ReplyDeleteStill equally positive as earlier, if one is looking for long term investment...
DeleteHi Kunal. Eagerly waiting for christmas and new year tips.
ReplyDeleteplsshare ur view on Kesar Terminals & Infrastructure Ltd. and TV today network.
Positive on both the stocks mentioned, as expressed earlier also...
DeleteHello and very very good evening sir, Thanks for providing such a blog. Sir i am tracking Indian Toners and Developers even though looking attractive at cmp 85 Kindly advise me on it. do you find any investment opportunity in it? Thanks a lot sir . GOD BLESS YOU
ReplyDeleteThanks for the appreciation...
DeleteNever looked at Indian Toners before... visited it for the first time, and frankly, it did look interesting...
Will do some detailed analysis, and let you know, if I find any risk factors...
hi kunal,
DeleteThis link may be helpful in analyzing the story of indian toners further...
http://smallcapvaluefind.blogspot.in/2014/10/indian-toners-developers-real-pioneer.html
your views on MIC electronics?
ReplyDeleteNot tracking MIC..
DeleteIs it advisable to invest in Ajanta Pharma in SIP mode even at this rate?
ReplyDelete- Ashish
Yes, I said previously also... there is never a bad time to enter a good stock...
DeleteWhen can we expect the new stock idea coming.
ReplyDeleteI think its hardly 10 days since the last new stock details were posted...
DeleteI am studying few stocks right now... will post once that is complete..
Dear Kunal,
ReplyDeletecan you give your views on sudarshan chemicals for long term, can it become a multibagger,
thanks
shailesh
At market cap of close to 1000 Cr in speciality chemical industry, it is difficult to predict if it can be a multibagger..
DeleteThe P/E ratio is also pretty fair for the company..
Being such a big company, not quite happy with their ROE..
Also, the debt levels are extremely high for company in this business..
Cash flow is inconsistent..
Apart from these, the data looks good. There was a lean patch from FY'11 to FY'13, where there was almost no growth. But company seems to have comeback well since then..
These are my views on first look of it. With this, I am not in position to give a conclusive answer.
You can use these data points to take your call..
Dear kunal .. V2 retail seems to be a very good buy at these levels . What do you think ?
ReplyDeleteHi Renu,
DeleteDifficult to comment as I am not tracking the company.
Plus, it seems to have a story behind its downfall, and then rising up again recently...
So, can't inform anything, unless I am aware of the entire history..
Sorry!!!
Regards.
please throw some light on Rain ind. - Ashish
ReplyDeleteNot tracking Rain Ind..
DeleteAny specific reason for rise in Granules even in such weak markets?
ReplyDeleteDon't see anything specific as of now...
DeleteAny views on Pressman Adv. if you track?
ReplyDelete-Mayur
Sorry not tracking...
DeleteHi Kunal,
ReplyDeletePls share ur view on Orient-Refractories
Its a decent company but not a case of undervaluation at current market price...
DeleteAnd what about IFGL Refractories?
ReplyDeleteIFGL is better placed in terms of valuation when compared to Orient Refractories...
DeleteHowever, the current year so far, has proved to be better for Orient when compared to IFGL..
As I am not a follower of either of these, its difficult to influence any reader to take a particular action...
Hi kunal, what is ur view on banco products pls.
ReplyDeletePositive on Banco Products for long term investors..
DeleteKunal, M holding granules from 150 levels but a few quantities, as m not in need of money, would you suggest to hold it for another year or so if you see value growth in it? want to see it trading in higher range of 3 digits...
ReplyDelete-Mayur
Not sure about 1 year, but it is definitely worth having in portfolio, at least some quantity...
DeleteHi Kunal,
ReplyDeleteIs there more scope for returns available in case of Camlin Fine Science, from these levels?
- Kumar
Camlin has got a good market share of its anti-oxidants products, which could drive the growth going forward, but at present, don't think its undervalued...
DeleteIf at all it is bought, it should be based on growth prospectus..
Finally Garware Wall Ropes got moving after being steady for long period..
ReplyDeleteNot tracking daily movements unless we have a specific announcement from the company..
DeleteThese are long term stories, so I generally dont get carried away by such short term movements... :)
Hello mr kunal happy new year thanks for your new yr find Garware wall add technocraft industries to it.
ReplyDeleteDear friend I need your esteemed opinion on this stock even if your not tracking it. I came across
ASSOCIATED ALCHOLOL & BREWERIES LTD and found the reported numbers very interesting like 35% CAGR rev gr in 3 yrs 40% profit growth in 3 yrs and the promoter is MR.ANAND KUMAR KEDIA a decent industrialist in Madhya Pradesh promoter holding 58% recently bought 6% in open market authrosied capital 1.1 cr issued capital .9 cr no preference capital. No warrants pending. The company is only supplier of Triple distelled grain spirit to Diageo Smirnoff vodka, only bottler of single malt whisky Glen Drummond, bottling agreemnt for Haig scoth, ENA supplier to Radico , Tilaknagr own IMFL brand jamesmcgill, redwhite
Happy New Year to you as well..
DeleteWill definitely try and have a look at Assoc Alcohol & Brew..
Thanks..
Sorry I continue fy 15 rev exp 300 cr and EBITA 36 cr NP around 16 cr and EPS around 15/ 16 historical PE around 10/11 sectoe PE is on the higher side all the above looks very interesting on the face of it I am requesting a seasoned investor like you to find something iam missing. It seems attractive only the sector seems a worry. But compared to peers it looks cheap. Please help me am I missing here something. Thanking you once again for your good work and happy new year to you and your family.
ReplyDeleteHere are some negatives:
Delete1) First of all, as you mentioned, sector is a worry.
2) Secondly, though the company has made good profit, they have not paid dividend, which raises the question on promoters.
3) ROE for the company is very low. When I calculated for last 3 years, it came out to be around 8%..
4) Debt is extremely high. For Mar'14, the ratio was close to almost 2, which is not so good for a small company. The good part, is that they have reduced it by a good margin as per Sep'14 result..
Apart from that, I feel the remaining data is good, and it can be taken as a study, to figure out if there is an investment opportunity here...
Thank you very much for having taken time to study and reply I owe you one brother. Once again thank u, I think the ROE will be a decent 13% in end fy15/16 and yes dividend is a lacking point.
ReplyDeleteHave a look also at TECHNOCRAFT INDUSTRIES 3 rd largest manufacturer of drum closure in the world yarn/ garment is a drag scaffolding is interesting.
One more news about GARWARE there is chance of defence order for all terrain tents .
Yes, positive on Technocraft for long term..
DeleteThe textile division is lagging and could act as resistance for company to move up smoothly...
But you never know, it is just a guess.
Overall, I like the company, though it has some minor negatives..
Is sharon bio a worth a case to study how big analyst confuse the retail investors and really i am not able to understand actually what is there outstanding equity after bounus/ split is it 21.1 cr or 100 cr very confusing is the sept qtr balance sheet showing 21.1 cr 10 Rs paid up share ie split is it 100 cr EQ. Can u throw some light.
ReplyDeletePlease try to put your queries on latest thread. It is difficult to go back to previous post and check..
DeletePaid equity share capital is 21.1 Cr, as seen in Sep as well as Mar qtr sheet. I didn't understand your query...
Here are both the result sheet, check point no 14, and let me know, if there is any confusion..
http://www.bseindia.com/xml-data/corpfiling/AttachHis/Sharon_Bio-Medicine_Ltd_150514_Rst.pdf
http://www.bseindia.com/xml-data/corpfiling/AttachHis/Sharon_Bio-Medicine_Ltd_131114_Rst.pdf